Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function. | Int J Mol Sci | 2022 | 35955928 | PubTator, text mining | PubMed |
| Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro. | Cells | 2022 | 35954219 | PubTator, text mining | PubMed |
| Endothelin-1 receptor blockade does not alter the sympathetic and hemodynamic response to acute intermittent hypoxia in men. | J Appl Physiol (1985) | 2022 | 35952348 | PubTator, text mining | PubMed |
| Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension. | JCI Insight | 2022 | 35951428 | PubTator, text mining | PubMed |
| CD39 in the development and progression of pulmonary arterial hypertension. | Purinergic Signal | 2022 | 35947229 | PubTator, text mining | PubMed |
| Integrative small and long RNA omics analysis of human healing and nonhealing wounds discovers cooperating microRNAs as therapeutic targets. | Elife | 2022 | 35942686 | PubTator, text mining | PubMed |
| Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury. | Front Cell Dev Biol | 2022 | 35938163 | PubTator, text mining | PubMed |
| Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms. | Front Pharmacol | 2022 | 35935861 | PubTator, text mining | PubMed |
| Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its N-terminal fragment 1 to 36. | J Biol Chem | 2022 | 35933010 | PubTator, text mining | PubMed |
| Novel psoralen derivatives as anti-breast cancer agents and their light-activated cytotoxicity against HER2 positive breast cancer cells. | Sci Rep | 2022 | 35931753 | PubTator, text mining | PubMed |
| Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia. | Int J Angiol | 2022 | 35923582 | PubTator, text mining | PubMed |
| Role of B-Cell in the Pathogenesis of Systemic Sclerosis. | Front Immunol | 2022 | 35903091 | PubTator, text mining | PubMed |
| Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients. | Transpl Immunol | 2022 | 35901953 | PubTator, text mining | PubMed |
| Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells. | Cell Cycle | 2022 | 35899934 | PubTator, text mining | PubMed |
| The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers. | Front Cardiovasc Med | 2022 | 35898267 | PubTator, text mining | PubMed |
| 17β-Estradiol promotes angiogenesis of bone marrow mesenchymal stem cells by upregulating the PI3K-Akt signaling pathway. | Comput Struct Biotechnol J | 2022 | 35891776 | PubTator, text mining | PubMed |
| Investigation of Biomarkers Associated with Low Platelet Counts in Normal Karyotype Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 35887121 | PubTator, text mining | PubMed |
| Intracerebral Hemorrhage Genetics. | Genes (Basel) | 2022 | 35886033 | PubTator, text mining | PubMed |
| The Role of PROX1 in Neoplasia: A Key Player Often Overlooked. | Diagnostics (Basel) | 2022 | 35885529 | PubTator, text mining | PubMed |
| Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights. | Biomedicines | 2022 | 35884811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=34